183 related articles for article (PubMed ID: 26194130)
1. Hepatocellular Carcinoma with Cervical Spine and Pelvic Bone Metastases Presenting as Unknown Primary Neoplasm.
Hwang SW; Lee JE; Lee JM; Hong SH; Lee MA; Chun HG; Chun HJ; Lee SH; Jung ES
Korean J Gastroenterol; 2015 Jul; 66(1):50-4. PubMed ID: 26194130
[TBL] [Abstract][Full Text] [Related]
2. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
Jiang W; Zeng ZC
Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma presenting with multiple bone and soft tissue metastases and atypical cytomorphological features--a rare case report.
Rastogi A; Bihari C; Jain D; Gupta NL; Sarin SK
Diagn Cytopathol; 2013 Jul; 41(7):640-3. PubMed ID: 21965139
[TBL] [Abstract][Full Text] [Related]
4. Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature.
Atkin C; Earwaker P; Pallan A; Shetty S; Punia P; Ma YT
BMC Gastroenterol; 2017 Feb; 17(1):30. PubMed ID: 28193171
[TBL] [Abstract][Full Text] [Related]
5. [A case of hepatocellular carcinoma treated by resection of metachronous rib metastasis after primary hepatectomy].
Takagi Y; Kametaka H; Makino H; Koyama T; Seike K; Hara J; Hasegawa A
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1834-6. PubMed ID: 23267902
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib in the treatment of recurrent hepatocellular carcinoma after liver transplantation: a report of four cases.
Hong YM; Yoon KT; Cho M; Kang DH; Kim HW; Choi CW; Park SB; Heo J; Woo HY; Lim W
Korean J Gastroenterol; 2015 Apr; 65(4):246-51. PubMed ID: 25896160
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: options for diagnosing and managing a deadly disease.
Murali AR; Romero-Marrero C; Aucejo F; Menon KV
Cleve Clin J Med; 2013 Oct; 80(10):645-53. PubMed ID: 24085810
[TBL] [Abstract][Full Text] [Related]
8. Chest wall metastases from unknown primary hepatocellular carcinoma.
Qureshi SS; Shrikhande SV; Borges AM; Shukla PJ
J Postgrad Med; 2005; 51(1):41-2. PubMed ID: 15793338
[TBL] [Abstract][Full Text] [Related]
9. Extrahepatic spread of hepatocellular carcinoma.
Cabibbo G; Compilato D; Genco C; Campisi G
Panminerva Med; 2012 Dec; 54(4):313-22. PubMed ID: 23123584
[TBL] [Abstract][Full Text] [Related]
10. Extrahepatic metastases of hepatocellular carcinoma.
Katyal S; Oliver JH; Peterson MS; Ferris JV; Carr BS; Baron RL
Radiology; 2000 Sep; 216(3):698-703. PubMed ID: 10966697
[TBL] [Abstract][Full Text] [Related]
11. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma.
Cho JY; Paik YH; Lim HY; Kim YG; Lim HK; Min YW; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Liver Int; 2013 Jul; 33(6):950-7. PubMed ID: 23601249
[TBL] [Abstract][Full Text] [Related]
12. Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results.
Cosgrove DP; Reyes DK; Pawlik TM; Feng AL; Kamel IR; Geschwind JF
Radiology; 2015 Nov; 277(2):594-603. PubMed ID: 26069923
[TBL] [Abstract][Full Text] [Related]
13. Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib.
Liu D; Liu A; Peng J; Hu Y; Feng X
Eur J Med Res; 2015 Feb; 20(1):12. PubMed ID: 25649133
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy.
Park JG
Clin Mol Hepatol; 2015 Sep; 21(3):287-94. PubMed ID: 26527250
[TBL] [Abstract][Full Text] [Related]
15. Next Generation of Preclinical Liver Cancer Models.
Weber A; O'Connor T; Heikenwalder M
Clin Cancer Res; 2015 Oct; 21(19):4254-6. PubMed ID: 26169964
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.
Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Kanai F; Yoshikawa M; Yokosuka O
Oncology; 2014; 87(6):330-41. PubMed ID: 25227534
[TBL] [Abstract][Full Text] [Related]
17. [Gastric metastasis of hepatocellular carcinoma treated by transarterial chemoembolization: a case report].
Kim JH; Park JW; Choi JI; Kim HB; Koh DW; Lee WJ; Kim CM
Korean J Hepatol; 2007 Mar; 13(1):91-5. PubMed ID: 17380079
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intermediate-stage hepatocellular carcinoma.
Finn RS
Clin Adv Hematol Oncol; 2015 Aug; 13(8):501-3. PubMed ID: 26351811
[No Abstract] [Full Text] [Related]
20. Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.
Gadaleta-Caldarola G; Divella R; Mazzocca A; Infusino S; Ferraro E; Filippelli G; Daniele A; Sabbà C; Abbate I; Brandi M
Future Oncol; 2015; 11(16):2263-6. PubMed ID: 26260805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
